NCT06489158 Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 Grade
| NCT ID | NCT06489158 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 168 participants |
| Start Date | 2024-09-09 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 168 participants in total. It began in 2024-09-09 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
1. Explore VOCs indicators that can effectively distinguish between benign and malignant breast diseases. 2. The accuracy of VOCs indicators and ultrasound 4a/4b/4c diagnosis will be compared in determining benign and malignant diseases based on pathological gold standards.
Eligibility Criteria
Inclusion Criteria: * Ultrasound examination within 3 months clearly indicates that breast lesions are BI-RADs4a/4b/4c * Surgical treatment within one week after Exhaled VOC test * informed consent form should be signed Exclusion Criteria: * Male * Women who have been diagnosed as breast cancer by puncture * Individuals with unclear BI-RADs level information by breast ultrasound, including but not limited to BI-RADs 4/3-4a/4a-b/4b-c * Pregnant or lactating women * A positive smoking history within one year * Medical history of malignant tumor, including but not limited to breast cancer (excluding skin basal cell carcinoma) * The past history of metabolic diseases, including diabetes, gout, etc * Respiratory diseases that have been clearly diagnosed in the past, such as asthma and chronic obstructive pulmonary emphysema, are not suitable for participation in the study * Previously diagnosed digestive system diseases, such as Helicobacter pylori positivity and gastric ulcers, are not suitable for participation in the study * Combination application of drugs related to the treatment of elderly dementia * Possible cases which researchers believe it is not suitable for this clinical research
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06489158 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 80 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06489158 currently recruiting?
Yes, NCT06489158 is actively recruiting participants. Contact the research team at 49950757@qq.com for enrollment information.
Where is the NCT06489158 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06489158 clinical trial?
NCT06489158 is sponsored by Peking Union Medical College Hospital. The trial plans to enroll 168 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.